TCL Archive Henschke Responds To Questions from The New York Times By Cancer History Project April 29, 2011
TCL Archive Motesanib Does Not Improve OS; Study Doesn’t Meet Primary Endpoint By Cancer History Project April 29, 2011
TCL Archive Raymond Weiss Reviews Confidential Report on I-ELCAP By Cancer History Project April 29, 2011
TCL Archive Beta Blockers Negate Harmful Recurrence Risks of ACE Inhibitors By Cancer History Project April 29, 2011
TCL Archive Study Validates “PEM” Scans As Biopsy Guidance Method By Cancer History Project April 29, 2011
TCL Archive Prostatectomy Lowers Death Risk Compared to Watchful Waiting By Cancer History Project April 29, 2011
TCL Archive Postponed Surgery For Low-Grade Prostate Cancer Adds No Risk By Cancer History Project April 29, 2011
TCL Archive Acupuncture Can Relieve Side Effects of Hormone Treatment By Cancer History Project April 29, 2011
Article Robert Mayer talks about the half-century of misses that preceded the development of daraxonrasib By Cancer History Project